CHARLES JOHNSON: Open Payments
NPI 1164520391 · HUDSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 18 payments from 6 companies in 2025. Trend: 2023 $185 · 2024 $237 · 2025 $499
Food & beverage: $483Education: $17
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $334 |
| Lilly USA, LLC | 3 | $69 |
| Astellas Pharma US Inc | 1 | $34 |
| PFIZER INC. | 2 | $31 |
| Ethicon US, LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Ozempic, MOUNJARO, Rybelsus, Veozah, PREVNAR 20, STRATAFIX, BREZTRI, ELIQUIS.
Industry payments across NY — which companies pay providers there.
